OpenVSafe by OpenVAERS
Search V-safe

4NE-20515-35141

4 vaccinations 16 coded responses 46 check-ins 16 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
501 / IA
Registered
2021-03-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-15
    Registered in v-safe
  2. 2021-03-15
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-15
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abdominal distension, Fluid retention, Hyperhidrosis, Peripheral swelling, Weight increased — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Sweating, water retention--swelling of abdomen and extremities, gained 5lbs since yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis — Feeling: Fair · Fever · Chills, Abdominal pain
    Free text: Sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis — Feeling: Fair · Chills, Headache, Fatigue or tiredness, Abdominal pain
    Free text: Sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis — Feeling: Good
    Free text: Occasional heavy sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis — Feeling: Good
    Free text: Excessive sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-05
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-05
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Chills, Fatigue or tiredness
    Adult check-in
  14. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-04-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Agitation, Anxiety, Blood pressure increased, Cold sweat, Heart rate increased, Hyperhidrosis, Nervousness, Panic reaction, Paraesthesia — Feeling: Fair · Fatigue or tiredness, Nausea
    Free text: Panicky feelings, butterflies in stomach, anxiety, cold sweats, hot sweats, tingling extremities, periods of increased heart rate and blood pressure, agitation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hyperhidrosis, Menstrual disorder — Feeling: Fair · Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Sweating, my menstrual cycle began 9 days early.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-26
    Survey response — day 21, dose 2
    MedDRA: Abnormal menstrual clots, Arthralgia, Chills, Dysmenorrhoea, Headache, Heavy menstrual bleeding, Hot flush, Menstrual disorder, Oligomenorrhoea, Peripheral coldness, Photophobia, Pre-existing disease, Raynaud's phenomenon — Feeling: Good · Be unable to do your normal daily activities
    Free text: Chills, headaches, joint pain, cold hands & feet (flare up of raynaunds), sensitivity to bright light. Abnormal menstrual cycle: Extremely heavy bleeding, severe cramping, numerous blood clots (large and small) and an extended cycle.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-04
    Survey response — 6 months, dose 2
    MedDRA: Bacterial infection, Dysmenorrhoea, Heavy menstrual bleeding, Pelvic infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pelvic bacterial infection Heavy and painful menstruation
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-08
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-08
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  32. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Joint pains, Fatigue or tiredness
    Adult check-in
  33. 2021-10-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  34. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-15
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-10-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-10-30
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-05
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-12
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-19
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-01-07
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-04-08
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  44. 2022-04-16
    Dose 4 — Pfizer-BioNTech
  45. 2022-04-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Energy increased, Insomnia — Feeling: Good · Site: Pain · Headache
    Free text: Insomnia and lots of energy
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-04-18
    Survey response — days 1–6 daily, dose 4
    MedDRA: Energy increased — Feeling: Good · Fever · Chills, Headache, Joint pains, Muscle or body aches
    Free text: Extra energy
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-04-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Cold sweat — Feeling: Good · Chills, Diarrhea
    Free text: Cold Sweats
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-04-20
    Survey response — days 1–6 daily, dose 4
    MedDRA: Cold sweat, Feeling hot, Hyperhidrosis — Feeling: Good · Chills
    Free text: Cold & hot sweats
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-04-21
    Survey response — days 1–6 daily, dose 4
    MedDRA: Cold sweat, Feeling hot, Hyperhidrosis — Feeling: Good
    Free text: Excessive sweating and hot/cold sweats
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-04-22
    Survey response — days 1–6 daily, dose 4
    MedDRA: Hyperhidrosis — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Sweating
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-04-23
    Survey response — day 7, dose 4
    MedDRA: Cold sweat, Hyperhidrosis — Feeling: Poor · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Cold sweats, excessive sweating
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-15Pfizer-BioNTech
22021-04-05Pfizer-BioNTech
32021-10-08Pfizer-BioNTech No
42022-04-16Pfizer-BioNTech No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-16

Systemic reaction (other): Sweating, water retention--swelling of abdomen and extremities, gained 5lbs since yesterday

2021-03-17

Systemic reaction (other): Sweating

2021-03-18

Systemic reaction (other): Sweating

Release 6 — days 1–6 daily, dose 1

2021-03-19

Systemic reaction (other): Occasional heavy sweating

2021-03-20

Systemic reaction (other): Excessive sweating

Release 7 — days 1–6 daily, dose 2

2021-04-08

Systemic reaction (other): Panicky feelings, butterflies in stomach, anxiety, cold sweats, hot sweats, tingling extremities, periods of increased heart rate and blood pressure, agitation

2021-04-09

Systemic reaction (other): Sweating, my menstrual cycle began 9 days early.

Release 8 — day 21, dose 2

2021-04-26

Symptoms: Chills, headaches, joint pain, cold hands & feet (flare up of raynaunds), sensitivity to bright light. Abnormal menstrual cycle: Extremely heavy bleeding, severe cramping, numerous blood clots (large and small) and an extended cycle.

Release 9 — 6 months, dose 2

2021-10-04

Symptoms: Pelvic bacterial infection Heavy and painful menstruation

Release 11 — days 1–6 daily, dose 4

2022-04-17

Systemic reaction (other): Insomnia and lots of energy

2022-04-18

Systemic reaction (other): Extra energy

2022-04-19

Systemic reaction (other): Cold Sweats

2022-04-20

Systemic reaction (other): Cold & hot sweats

2022-04-21

Systemic reaction (other): Excessive sweating and hot/cold sweats

2022-04-22

Systemic reaction (other): Sweating

Release 11 — day 7, dose 4

2022-04-23

Systemic reaction (other): Cold sweats, excessive sweating

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbnormal menstrual clots ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBacterial infection · · ✓
SDChills ✓ ✓ ✓
SDDysmenorrhoea ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDHot flush ✓ ✓ ✓
SDMenstrual disorder ✓ ✓ ✓
SDOligomenorrhoea ✓ ✓ ✓
SDPelvic infection · · ✓
SDPeripheral coldness ✓ ✓ ✓
SDPhotophobia ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRaynaud's phenomenon ✓ ✓ ✓
SROAbdominal distension ✓ ✓ ✓
SROAgitation ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓
SROBlood pressure increased ✓ ✓ ✓
SROCold sweat ✓ ✓ ✓
SROEnergy increased · · ✓
SROFeeling hot · · ✓
SROFluid retention ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROInsomnia · · ✓
SROMenstrual disorder ✓ ✓ ✓
SRONervousness ✓ ✓ ✓
SROPanic reaction ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROPeripheral swelling ✓ ✓ ✓
SROWeight increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…